Edwards Lifesciences Corporation

EWNYSEHealthcare● Active

$85.96

$-1.49(-1.70%)

Market Cap$49.5B

P/E Ratio—

52W High$89.445

52W Low$72.3

Avg Volume5.1M

Open$88.24

Beta0.87

Cash on Hand Financials Revenue

Edwards Lifesciences Corporation (EW) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

EW · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$4.23B▲ +6.3% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$2.94B

cashAndCashEquivalents

Short-Term Investments

$1.29B

shortTermInvestments

YoY Change vs Prior Year

+6.3%

vs prior fiscal year

Latest Quarter

$3.67B

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$4.23BCash on Hand

Total Debt$705.4MTotal Debt

Net Cash / Net Debt+$3.52BNet Cash Position

Cash vs Debt Ratio

Cash 86%Edwards Lifesciences Corporation cash as % of market cap: 8.54%% · MCap $49BDebt 14%

Edwards Lifesciences Corporation has a net cash position of $3.52B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$4.23B − $705.4M = +$3.52B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

EW annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

EW cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$4.23B+6.3%

Dec 31, 2024FY$3.98B+143.5%

Dec 31, 2023FY$1.63B+34.4%

Dec 31, 2022FY$1.22B-17.1%

Dec 31, 2021FY$1.47B+4.6%

EW cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

EW vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Edwards Lifesciences CorporationYOU

$4.23B$49B8.5%

15%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Edwards Lifesciences Corporation (EW) cash on hand as of December 31, 2025 is $4.23B, comprising $2.94B in cash and cash equivalents (CCE) plus $1.29B in short-term investments — reported as Edwards Lifesciences Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Edwards Lifesciences Corporation cash reserves or cash position.

Edwards Lifesciences Corporation annual cash on hand history shows increased +6.3% in 2025: increased +6.3% in 2025. Edwards Lifesciences Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Edwards Lifesciences Corporation carries total debt of $705.4M against cash of $4.23B, resulting in a net cash position of +$3.52B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

EW cash on hand · 5 questions

As of December 31, 2025, Edwards Lifesciences Corporation (EW) has $4.23B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2.94B in cash and cash equivalents (CCE) plus $1.29B in short-term investments. Latest quarter (March 31, 2026): $3.67B. Data sourced from the annual 10-K filing via FMP.

EW cash on handEW cash reservesEW cash 2025how much cash does EW have

▸ Source: FMP /balance-sheet-statement · US GAAP · Edwards Lifesciences Corporation · Edwards Lifesciences Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025